Hippocampal metabolomics using ultrahigh-resolution mass spectrometry reveals neuroinflammation from Alzheimer's disease in CRND8 mice

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 15, 2013, Pages 5105-5117

  Lin, Shuhai ^a   Liu, Hongde ^b   Kanawati, Basem ^c   Liu, Liangfeng ^a   Dong, Jiyang ^d   Li, Min ^a   Huang, Jiandong ^e   Schmitt Kopplin, Philippe ^c,f   Cai, Zongwei ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b SOUTHEAST UNIVERSITY   (China)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d XIAMEN UNIVERSITY   (China)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Alzheimer's disease; Arachidonic acid metabolism; FTMS; Hippocampus; Metabolomics

Indexed keywords

ALZHEIMER'S DISEASE; ARACHIDONIC ACIDS; FTMS; HIPPOCAMPUS; METABOLOMICS;

BIOINFORMATICS; BRAIN; LIQUID CHROMATOGRAPHY; MAMMALS; MASS SPECTROMETRY; METABOLITES; PHYSIOLOGY; PROTEINS; TISSUE; TOXICITY; UNSATURATED FATTY ACIDS;

METABOLISM;

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; GENETICS; HIPPOCAMPUS; INFLAMMATION; MALE; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METHODOLOGY; MOUSE; MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; HIPPOCAMPUS; INFLAMMATION; MALE; MASS SPECTROMETRY; METABOLOMICS; MICE; MICE, TRANSGENIC; MUTATION;

MUS;

EID: 84878289356     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-6825-1     Document Type: Article

References (38)

1. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653-683
2. Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, Niesporek S, Konsgen D, Dietel M, Fiehn O (2006) Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res 66(22):10795-10804
3. Southam AD, Payne TG, Cooper HJ, Arvanitis TN, Viant MR (2007) Dynamic range and mass accuracy of wide-scan direct infusion nanoelectrospray fourier transform ion cyclotron resonance mass spectrometry-based metabolomics increased by the spectral stitching method. Anal Chem 79(12):4595-4602
4. Aharoni A, Ric de Vos CH, Verhoeven HA, Maliepaard CA, Kruppa G, Bino R, Goodenowe DB (2002) Nontargeted metabolome analysis by use of fourier transform ion cyclotron mass spectrometry. OMICS 6(3):217-234
5. Ohta D, Kanaya S, Suzuki H (2010) Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification. Curr Opin Biotechnol 21(1):35-44
6. Jansson J, Willing B, Lucio M, Fekete A, Dicksved J, Halfvarson J, Tysk C, Schmitt-Kopplin P (2009) Metabolomics reveals metabolic biomarkers of Crohn's disease. PLoS One 4(7):e6386
7. Lucio M, Fekete A, Weigert C, Wagele B, Zhao XJ, Chen J, Fritsche A, Haring HU, Schleicher ED, Xu GW, Schmitt-Kopplin P, Lehmann R (2010) Insulin sensitivity is reflected by characteristic metabolic fingerprints - a fourier transform mass spectrometric Non-targeted metabolomics approach. PLoS One 5(10):e13317
8. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-Hyslop PS, Westaway D (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276(24):21562-21570
9. Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, De Strooper B, Vanderstichele H, Lofgren A, Vanderhoeven I, Backhovens H, Vanmechelen E, Kroisel PM, Van Broeckhoven C (2000) Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. Hum Mol Genet 9(18):2589-2598
10. De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, Annaert W, Van Broeckhoven C, De Strooper B (2001) Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet 10(16):1665-1671
11. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nat Med 1:1291-1296
12. Rustay NR, Cronin EA, Curzon P, Markosyan S, Bitner RS, Ellis TA, Waring JF, Decker MW, Rueter LE, Browman KE (2010) Mice expressing the Swedish APP mutation on a 129 genetic background demonstrate consistent behavioral deficits and pathological markers of Alzheimer's disease. Brain Res 1311:136-147
13. Rabe S, Reichwald J, Ammaturo D, de Strooper B, Saftig P, Neumann U, Staufenbiel M (2011) The Swedish APP mutation alters the effect of genetically reduced BACE1 expression on the APP processing. J Neurochem 119(1):231-239
14. Lin S, Yang Z, Liu H, Tang L, Cai Z (2011) Beyond glucose: metabolic shifts in responses to the effects of the oral glucose tolerance test and the high-fructose diet in rats. Mol Biosyst 7(5):1537-1548
15. Lin S, Yang Z, Zhang X, Bian Z, Cai Z (2011) Hippocampal metabolomics reveals 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity associated with ageing in Sprague-Dawley rats. Talanta 85(2):1007-1012
16. He C, Wu Y, Lai Y, Cai Z, Liu Y, Lai L (2012) Dynamic eicosanoid responses upon different inhibitor and combination treatments on the arachidonic acid metabolic network. Mol Biosyst 8(5):1585-1594
17. Bijlsma S, Bobeldijk I, Verheij ER, Ramaker R, Kochhar S, Macdonald IA, van Ommen B, Smilde AK (2006) Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem 78(2):567-574
18. Suhre K, Schmitt-Kopplin P (2008) MassTRIX: mass translator into pathways. Nucleic Acids Res 36(Web Server issue):W481-W484
19. Wang L, Chu F, Xie W (2007) Accurate cancer classification using expressions of very few genes. IEEE/ACM Trans Comput Biol Bioinform 4(1):40-53
20. Liger-Belair G, Cilindre C, Gougeon RD, Lucio M, Gebefugi I, Jeandet P, Schmitt-Kopplin P (2009) Unraveling different chemical fingerprints between a champagne wine and its aerosols. Proc Natl Acad Sci U S A 106(39):16545-16549
21. Weber RJ, Southam AD, Sommer U, Viant MR (2011) Characterization of isotopic abundance measurements in high resolution FT-ICR and Orbitrap mass spectra for improved confidence of metabolite identification. Anal Chem 83(10):3737-3743
22. Bae E, Yeo IJ, Jeong B, Shin Y, Shin KH, Kim S (2011) Study of double bond equivalents and the numbers of carbon and oxygen atom distribution of dissolved organic matter with negative-mode FT-ICR MS. Anal Chem 83(11):4193-4199
23. Lobodin VV, Marshall AG, Hsu CS (2012) Compositional space boundaries for organic compounds. Anal Chem 84(7):3410-3416
24. Stephenson DT, Lemere CA, Selkoe DJ, Clemens JA (1996) Cytosolic phospholipase A(2) (cPLA(2)) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3(1):51-63
25. Malle E, Bollmann A, Steinmetz A, Gemsa D, Leis HJ, Sattler W (1997) Serum amyloid A (SAA) protein enhances formation of cyclooxygenase metabolites of activated human monocytes. FEBS Lett 419(2-3):215-219
26. Schulte EC, Slawik H, Schule R, Gunther T, Hull M (2009) Alterations in excitotoxicity and prostaglandin metabolism in a transgenic mouse model of Alzheimer's disease. Neurochem Int 55(7):689-696
27. Sanchez-Mejia RO, Mucke L (2010) Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta 1801(8):784-790
28. Amtul Z, Uhrig M, Wang L, Rozmahel RF, Beyreuther K (2012) Detrimental effects of arachidonic acid and its metabolites in cellular and mouse models of Alzheimer's disease: structural insight. Neurobiol Aging 33(4):831, e21-31
29. Kimura M, Yamaguchi S (1999) Screening for fatty acid beta oxidation disorders. Acylglycine analysis by electron impact ionization gas chromatography-mass spectrometry. J Chromatogr B: Biomed Sci Appl 731(1):105-110
30. Fourcade S, Ruiz M, Camps C, Schluter A, Houten SM, Mooyer PA, Pampols T, Dacremont G, Wanders RJ, Giros M, Pujol A (2009) A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis. Am J Physiol Endocrinol Metab 296(1):E211-E221
31. Steinberg JG, Delliaux S, Jammes Y (2006) Reliability of different blood indices to explore the oxidative stress in response to maximal cycling and static exercises. Clin Physiol Funct Imag 26(2):106-112
32. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, McGowan E, Emson PC, Griffin JL (2010) A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int 56(8):937-947
33. Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F (2004) Inflammation occurs early during the Abeta deposition process in TgCRND8 mice. Neurobiol Aging 25(7):861-871
34. Ruan L, Kang Z, Pei G, Le Y (2009) Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease. Curr Alzheimer Res 6(6):531-540
35. Ferretti MT, Bruno MA, Ducatenzeiler A, Klein WL, Cuello AC (2012) Intracellular Abeta-oligomers and early inflammation in a model of Alzheimer's disease. Neurobiol Aging 33(7):1329-1342
36. Rojo LE, Fernandez JA, Maccioni AA, Jimenez JM, Maccioni RB (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 39(1):1-16
37. Rosenberg PB (2005) Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry 17(6):503-514
38. Trepanier CH, Milgram NW (2010) Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy? J Alzheimers Dis 21(4):1089-1099